Molecular markers for resistance against infectious diseases of economic importance von Prajapati, B M, Gupta, J P, Pandey, D P, Parmar, G A, Chaudhari, J D

Volltext

Utility of first lactation fat energy corrected milk yield as a trait for genetic evaluation of Mehsana buffalo bulls using various sire evaluation methods von Prajapati, B. M., Gupta, J. P., Chaudhari, J. D., Parmar, G. A., Sathwara, R. N., Panchasara, H. H., Patel, P. A., Prajapati, M. N.

Volltext

Effectiveness of various sire evaluation methods in ranking Mehsana bulls based on FL305MY and TMY under field progeny testing programme von CHAUDHARI, J D, GUPTA, J P, PANDEY, D P, SHAH, R R, PRAJAPATI, B M, PARMAR, G A, PRAJAPATI, M N, PATEL, P A, PRAJAPATI, K B, PRAJAPATI, B H

Volltext

Erythrocyte agglutination by wheat germ agglutinin: ionic strength dependence of the contact seam topology von M. Rolfe, A. Parmar, T. G. Hoy, W. T. Coakley

Volltext

Is ultrasonography essential before surgery in eyes with advanced cataracts? von Salman Amjad, Parmar P, Vanila CG, Thomas PA, Nelson Jesudasan CA

Volltext

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial von Rustin, Gordon JS, Prof, van der Burg, Maria EL, MD, Griffin, Clare L, MSc, Guthrie, David, FRCR, Lamont, Alan, FRCR, Jayson, Gordon C, Prof, Kristensen, Gunnar, MD, Mediola, César, MD, Coens, Corneel, MSc, Qian, Wendi, PhD, Parmar, Mahesh KB, Prof, Swart, Ann Marie, Dr

Volltext

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study von Ahmed, Hashim U, FRCS, El-Shater Bosaily, Ahmed, MBBCh, Brown, Louise C, PhD, Gabe, Rhian, PhD, Kaplan, Richard, Prof, Parmar, Mahesh K, Prof, Collaco-Moraes, Yolanda, PhD, Ward, Katie, BSc, Hindley, Richard G, FRCS, Freeman, Alex, FRCPath, Kirkham, Alex P, FRCR, Oldroyd, Robert, MA, Parker, Chris, FRCR, Emberton, Mark, Prof

Volltext

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial von Warde, Padraig, Dr, Mason, Malcolm, MB, Ding, Keyue, PhD, Kirkbride, Peter, MB, Brundage, Michael, MD, Cowan, Richard, MB, Gospodarowicz, Mary, MD, Sanders, Karen, BSc, Kostashuk, Edmund, MD, Swanson, Greg, MD, Barber, Jim, MB, Hiltz, Andrea, MSc, Parmar, Mahesh KB, PhD, Sathya, Jinka, MB, Anderson, John, MB, Hayter, Charles, MD, Hetherington, John, MB, Sydes, Matthew R, CStat, Parulekar, Wendy, MD

Volltext

Computational Radiomics System to Decode the Radiographic Phenotype von van Griethuysen, Joost J M, Fedorov, Andriy, Parmar, Chintan, Hosny, Ahmed, Aucoin, Nicole, Narayan, Vivek, Beets-Tan, Regina G H, Fillion-Robin, Jean-Christophe, Pieper, Steve, Aerts, Hugo J W L

Volltext

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy von James, Nicholas D, de Bono, Johann S, Spears, Melissa R, Clarke, Noel W, Mason, Malcolm D, Dearnaley, David P, Ritchie, Alastair W.S, Amos, Claire L, Gilson, Clare, Jones, Rob J, Matheson, David, Millman, Robin, Attard, Gerhardt, Chowdhury, Simon, Cross, William R, Gillessen, Silke, Parker, Christopher C, Russell, J. Martin, Berthold, Dominik R, Brawley, Chris, Adab, Fawzi, Aung, San, Birtle, Alison J, Bowen, Jo, Brock, Susannah, Chakraborti, Prabir, Ferguson, Catherine, Gale, Joanna, Gray, Emma, Hingorani, Mohan, Hoskin, Peter J, Lester, Jason F, Malik, Zafar I, McKinna, Fiona, McPhail, Neil, Money-Kyrle, Julian, O’Sullivan, Joe, Parikh, Omi, Protheroe, Andrew, Robinson, Angus, Srihari, Narayanan N, Thomas, Carys, Wagstaff, John, Wylie, James, Zarkar, Anjali, Parmar, Mahesh K.B, Sydes, Matthew R

Volltext

Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers von Trebeschi, S., Drago, S.G., Birkbak, N.J., Kurilova, I., Cǎlin, A.M., Delli Pizzi, A., Lalezari, F., Lambregts, D.M.J., Rohaan, M.W., Parmar, C., Rozeman, E.A., Hartemink, K.J., Swanton, C., Haanen, J B A G, Blank, C.U., Smit, E.F., Beets-Tan, R.G.H., Aerts, H.J.W.L

Volltext

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial von Dearnaley, David P, Prof, Jovic, Gordana, PhD, Syndikus, Isabel, FRCR, Khoo, Vincent, FRCR, Cowan, Richard A, FRCR, Graham, John D, FRCR, Aird, Edwin G, PhD, Bottomley, David, FRCR, Huddart, Robert A, FRCR, Jose, Chakiath C, FRANZCR, Matthews, John H L, FRANZCR, Millar, Jeremy L, FRANZCR, Murphy, Claire, BSc, Russell, J Martin, FRCR, Scrase, Christopher D, FRCR, Parmar, Mahesh K B, Prof, Sydes, Matthew R, MSc

Volltext

Dissipation kinetics of co-formulation with two herbicides, clodinafop-propargyl and oxyfluorfen, in/on onion (Allium cepa) samples von Litoriya, Nitesh S., Chauhan, Nirmal R., Kalasariya, Ravi L., Parmar, Kaushik D., Chawla, Suchi, Parmar, Ambalal V., Raj, Pratik V., Shah, Paresh G.

Volltext

Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy? von Langley, R E, Burdett, S, Tierney, J F, Cafferty, F, Parmar, M K B, Venning, G

Volltext

30-Year Trends in Stroke Rates and Outcome in Auckland, New Zealand (1981-2012): A Multi-Ethnic Population-Based Series of Studies von Feigin, Valery L, Krishnamurthi, Rita V, Barker-Collo, Suzanne, McPherson, Kathryn M, Barber, P Alan, Parag, Varsha, Arroll, Bruce, Bennett, Derrick A, Tobias, Martin, Jones, Amy, Witt, Emma, Brown, Paul, Abbott, Max, Bhattacharjee, Rohit, Rush, Elaine, Suh, Flora Minsun, Theadom, Alice, Rathnasabapathy, Yogini, Te Ao, Braden, Parmar, Priya G, Anderson, Craig, Bonita, Ruth

Volltext

Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial von Parker, Christopher C, Clarke, Noel W, Cook, Adrian D, Kynaston, Howard G, Petersen, Peter Meidahl, Catton, Charles, Cross, William, Logue, John, Parulekar, Wendy, Payne, Heather, Persad, Rajendra, Pickering, Holly, Saad, Fred, Anderson, Juliette, Bahl, Amit, Bottomley, David, Brasso, Klaus, Chahal, Rohit, Cooke, Peter W, Eddy, Ben, Gibbs, Stephanie, Goh, Chee, Gujral, Sandeep, Heath, Catherine, Henderson, Alastair, Jaganathan, Ramasamy, Jakobsen, Henrik, James, Nicholas D, Kanaga Sundaram, Subramanian, Lees, Kathryn, Lester, Jason, Lindberg, Henriette, Money-Kyrle, Julian, Morris, Stephen, O'Sullivan, Joe, Ostler, Peter, Owen, Lisa, Patel, Prashant, Pope, Alvan, Popert, Richard, Raman, Rakesh, Røder, Martin Andreas, Sayers, Ian, Simms, Matthew, Wilson, Jim, Zarkar, Anjali, Parmar, Mahesh K B, Sydes, Matthew R

Volltext

Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents von Yang, H, Bueso-Ramos, C, DiNardo, C, Estecio, M R, Davanlou, M, Geng, Q-R, Fang, Z, Nguyen, M, Pierce, S, Wei, Y, Parmar, S, Cortes, J, Kantarjian, H, Garcia-Manero, G

Volltext

Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial von Eisen, Tim, Frangou, Eleni, Oza, Bhavna, Ritchie, Alastair W. S., Smith, Benjamin, Kaplan, Rick, Davis, Ian D., Stockler, Martin R., Albiges, Laurence, Escudier, Bernard, Larkin, James, Bex, Axel, Joniau, Steven, Hancock, Barry, Hermann, Gregers G., Bellmunt, Joaquim, Hodgkinson, Elizabeth, Stewart, Grant D., Barber, Jim, Brown, Janet, McMenemin, Rhona, Nathan, Paul, Pickering, Lisa M., Parmar, Mahesh K. B., Meade, Angela

Volltext

New approaches for brain repair—from rescue to reprogramming von Barker, Roger A., Götz, Magdalena, Parmar, Malin

Volltext

What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis von Vale, C.L., Fisher, D.J., White, I.R., Carpenter, J.R., Burdett, S., Clarke, N.W., Fizazi, K., Gravis, G., James, N.D., Mason, M.D., Parmar, M.K.B., Rydzewska, L.H., Sweeney, C.J., Spears, M.R., Sydes, M.R., Tierney, J.F.

Volltext